Ana De Vera

Title: Ana De Vera: Innovator in S1P Receptor Modulation

Introduction

Ana De Vera is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis and other inflammatory disorders. With a total of 2 patents, her work focuses on innovative dosage regimens for S1P receptor modulators.

Latest Patents

Ana De Vera's latest patents include a dosage regimen of an S1P receptor modulator aimed at treating patients suffering from multiple sclerosis. This invention emphasizes the importance of testing patients for a history of infection caused by the varicella zoster virus and ensuring they are vaccinated prior to the administration of the modulator. Another patent also addresses the treatment of inflammatory or autoimmune disorders, specifically detailing a regimen for administering fingolimod or its pharmaceutically acceptable salts at a daily dosage of 0.5 mg.

Career Highlights

Throughout her career, Ana has worked with notable companies, including Novartis AG. Her expertise in the field has allowed her to develop innovative solutions that enhance patient care and treatment outcomes.

Collaborations

Ana has collaborated with esteemed colleagues such as Craig Boulton and Pascale Burtin, contributing to the advancement of research and development in her area of expertise.

Conclusion

Ana De Vera is a trailblazer in the field of S1P receptor modulation, with her patents paving the way for improved treatment strategies for multiple sclerosis and other disorders. Her contributions continue to impact the medical community positively.